Spago Radionuclide therapy-arkiv - BioStock

Spago Nanomedical_2024 Momentum

2023 springboard for Spago’s radionuclide cancer therapy

9 februari, 2024

Spago_TumoradPhase1_FirstPatient

First patient dosed in Spago’s phase I/IIa trial

14 december, 2023

Spago Australia approval

Spago Nanomedical’s promising cancer therapy approved for phase I/IIa

23 oktober, 2023

Nyhetssvepet onsdag 4 december

Nyhetssvepet tisdag 3 december

3 december, 2024